COVID-19/SARS-COV-2 / RESEARCH LETTER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
There is growing attention towards the possible long-term effect of COVID-19 on neuropsychiatric disorders.

Material and methods:
We tested the effect of a combined nutraceutical (Synaid) with known nootropic effects in 40 elderly patients with self-perceived cognitive decline after SARS-CoV-2 infection, treated at home or in hospital.

Results:
After 3 months of treatment, Synaid significantly improved functional status, MMSE and the main psychological disorders associated with mild cognitive impairment, both in patients previously cared for at home and in hospital because of SARS-CoV-2 infection.

Conclusions:
Synaid was well tolerated and effective in improving cognitive function and psychosocial parameters after SARS-CoV-2 infection.

eISSN:1896-9151
ISSN:1734-1922